Choosing appropriate antimicrobial therapy is no longer a simple process. Even for the common problems of respiratory tract disease in children and adults, selection is complicated by both increasing microbial resistance and the daunting number of extended-spectrum antibiotics now on the market. In this article, Drs Singh and Arrieta look at the problem from all aspects and give their specific recommendations.